With our methylcobalamin, the injection dosage is 1,200 g per 0.3 mL syringe
BPC-157 Mechanism: The VEGF/Akt/eNOS Chain and Controlled Angiogenesis BPC-157 (Body Protection Compound 157) is a fragment of the gastric protein BPC, first isolated and characterized by Predrag Sikiric's team at the University of Zagreb in 1993
Emerging research further points to its anti-aging effects through collagen synthesis, as well as analgesic benefits [37, 38]
Neuroprotective Effects Emerging evidence suggests BPC-157 may help protect the brain and nerves
Geiss A, Larsson K, Junevik K, Rydevik B, Olmarker K
TB-500 (Thymosin Beta-4) represents another valuable combination partner